Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-02 Purchase | 2022-09-06 4:35 pm | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 10,000 | $21.22 | $212,194 | 10,000 (Direct) | View |
| 2020-08-18 Sale | 2020-08-20 8:17 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $100 | $1,500,000 | 169,883 (Direct) | View |
| 2020-07-15 Sale | 2020-07-17 8:01 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $80.07 | $1,201,070 | 184,883 (Direct) | View |
| 2019-12-19 Sale | 2019-12-20 9:00 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 495 | $60 | $29,700 | 494 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-24 Option Award | 2024-05-29 4:05 pm | N/A 2034-05-24 | Allakos Inc. | ALLK | Thomas Dolca Director | 41,000 | $0 | 41,000 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A 2032-05-25 | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 13,300 | $26.12 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A 2030-10-05 | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 23,522 | $25.23 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 13,300 | $0 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A 2031-06-03 | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 5,948 | $23.19 | 0 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 6:03 pm | N/A 2033-08-01 | Allakos Inc. | ALLK | Thomas Dolca Director | 154,786 | $0 | 154,786 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-31 7:21 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 3,300 | $0 | 13,300 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 6:25 pm | N/A 2032-05-25 | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 16,600 | $0 | 16,600 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:38 pm | N/A 2031-06-03 | CHINOOK THERAPEUTICS INC. | KDNY | Thomas Dolca Director | 5,948 | $0 | 5,948 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-13 4:20 pm | N/A 2031-01-10 | Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer | 450,000 | $0 | 450,000 (Direct) | View |
Ownership | 2021-01-13 4:19 pm | N/A N/A | Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2020-10-06 Option Award | 2020-10-07 9:06 pm | N/A 2030-10-05 | ADURO BIOTECH INC. | KDNY | Thomas Dolca Director | 23,522 | $0 | 23,522 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:16 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 283,057 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:16 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 2,207 | $100 | 0 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 169,883 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 169,883 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 184,883 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 184,883 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:28 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |